Comparison of Post-Inflammatory Pigment Alteration After Psoriasis Treatment (PIPA - Dermavant)

PHASE2/PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 15, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
ICD10 Code L40.9 for Psoriasis
Interventions
DRUG

Betamethasone dipropionate 0.05%

0.05% cream group will be treated once daily on both legs until clear or up to 12 weeks

DRUG

Tapinarof

1% tapinarof cream applied once daily to both legs until clear or up to 12 weeks

Trial Locations (1)

27157

Wake Forest University Health Sciences Department of Dermatology, Winston-Salem

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Dermavant Sciences, Inc.

INDUSTRY

lead

Wake Forest University Health Sciences

OTHER